Resolution of Fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin

被引：24

作者：

Apostolidis, J

Bouzani, M

Platsouka, E

Belasiotou, H

Stamouli, M

Harhalakis, N

Boutati, EI

Paniara, O

Nikiforakis, E

机构：

[1] Univ Athens, Evangelismos Hosp, Dept Hematol & Lymphoma, Athens 10676, Greece

[2] Univ Athens, Evangelismos Hosp, Dept Microbiol, Athens 10676, Greece

[3] Univ Athens, Evangelismos Hosp, Dept Internal Med 2, Athens 10676, Greece

来源：

CLINICAL INFECTIOUS DISEASES | 2003年 / 36卷 / 10期

关键词：

D O I：

10.1086/374895

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1349 / 1350

页数：2

共 5 条

[1]

ANAISSIE EJ, 1992, J INFECT DIS, V165, P1155, DOI 10.1093/infdis/165.6.1155

[2] Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management [J].

Boutati, EI ;

Anaissie, EJ .

BLOOD, 1997, 90 (03) :999-1008

[3] The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro [J].

Bowman, JC ;

Hicks, PS ;

Kurtz, MB ;

Rosen, H ;

Schmatz, DM ;

Liberator, PA ;

Douglas, CM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :3001-3012

[4] Comparison of caspofungin and amphotericin B for invasive candidiasis. [J].

Mora-Duarte, J ;

Betts, R ;

Rotstein, C ;

Colombo, AL ;

Thompson-Moya, L ;

Smietana, J ;

Lupinacci, R ;

Sable, C ;

Kartsonis, N ;

Perfect, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2020-2029

[5] In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi [J].

Pfaller, MA ;

Marco, F ;

Messer, SA ;

Jones, RN .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (04) :251-255

← 1 →